REASSURED diagnostics to inform disease control strategies, strengthen health systems and improve patient outcomes

KJ Land, DI Boeras, XS Chen, AR Ramsay… - Nature …, 2019 - nature.com
Lack of access to quality diagnostics remains a major contributor to health burden in
resource-limited settings. It has been more than 10 years since ASSURED (affordable …

New developments in tuberculosis diagnosis and treatment

CM Gill, L Dolan, LM Piggott, AM McLaughlin - Breathe, 2022 - Eur Respiratory Soc
Tuberculosis (TB) is a major cause of morbidity and mortality worldwide. It is estimated that
25% of the world's population are infected with Mycobacterium tuberculosis, with a 5–10 …

Advances in the development of new tuberculosis drugs and treatment regimens

A Zumla, P Nahid, ST Cole - Nature reviews Drug discovery, 2013 - nature.com
Despite the introduction 40 years ago of the inexpensive and effective four-drug (isoniazid,
rifampicin, pyrazinamide and ethambutol) treatment regimen, tuberculosis (TB) continues to …

Prevalence of tuberculosis in post-mortem studies of HIV-infected adults and children in resource-limited settings: a systematic review and meta-analysis

RK Gupta, SB Lucas, KL Fielding, SD Lawn - Aids, 2015 - journals.lww.com
Objectives: Tuberculosis (TB) is estimated to be the leading cause of HIV-related deaths
globally. However, since HIV-associated TB frequently remains unascertained, we …

Forty years of molecular diagnostics for infectious diseases

JE Schmitz, CW Stratton, DH Persing… - Journal of Clinical …, 2022 - Am Soc Microbiol
Nearly 40 years have elapsed since the invention of the PCR, with its extremely sensitive
and specific ability to detect nucleic acids via in vitro enzyme-mediated amplification. In turn …

Rapid urine-based screening for tuberculosis in HIV-positive patients admitted to hospital in Africa (STAMP): a pragmatic, multicentre, parallel-group, double-blind …

A Gupta-Wright, EL Corbett, JJ van Oosterhout… - The Lancet, 2018 - thelancet.com
Background Current diagnostics for HIV-associated tuberculosis are suboptimal, with
missed diagnoses contributing to high hospital mortality and approximately 374 000 annual …

Urogenital tuberculosis—epidemiology, pathogenesis and clinical features

A Muneer, B Macrae, S Krishnamoorthy… - Nature Reviews …, 2019 - nature.com
Tuberculosis (TB) is the most common cause of death from infectious disease worldwide. A
substantial proportion of patients presenting with extrapulmonary TB have urogenital TB (UG …

Diagnostic accuracy of the Xpert MTB/RIF assay for extrapulmonary and pulmonary tuberculosis when testing non-respiratory samples: a systematic review

L Maynard-Smith, N Larke, JA Peters, SD Lawn - BMC infectious diseases, 2014 - Springer
Background Although the evidence base regarding the use of the Xpert MTB/RIF assay for
diagnosis of pulmonary tuberculosis (TB) when testing respiratory samples is well …

Molecular Targets Related Drug Resistance Mechanisms in MDR-, XDR-, and TDR-Mycobacterium tuberculosis Strains

HMA Hameed, MM Islam, C Chhotaray… - Frontiers in cellular …, 2018 - frontiersin.org
Tuberculosis (TB) is a formidable infectious disease that remains a major cause of death
worldwide today. Escalating application of genomic techniques has expedited the …

[HTML][HTML] Laboratory diagnosis of extra-pulmonary tuberculosis (EPTB) in resource-constrained setting: state of the art, challenges and the need

M Purohit, T Mustafa - Journal of clinical and diagnostic research …, 2015 - ncbi.nlm.nih.gov
During the last decade, remarkable progress has been made in the diagnostics of
pulmonary tuberculosis; however, diagnostic challenges in extra-pulmonary tuberculosis …